These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 26150116)
21. Development and evaluation of sustained-release clonidine-loaded PLGA microparticles. Gaignaux A; Réeff J; Siepmann F; Siepmann J; De Vriese C; Goole J; Amighi K Int J Pharm; 2012 Nov; 437(1-2):20-8. PubMed ID: 22903047 [TBL] [Abstract][Full Text] [Related]
22. Kinetics of solvent extraction/evaporation process for PLGA microparticle fabrication. Katou H; Wandrey AJ; Gander B Int J Pharm; 2008 Nov; 364(1):45-53. PubMed ID: 18782610 [TBL] [Abstract][Full Text] [Related]
23. Fluphenazine release from biodegradable microparticles: characterization and modelling of release. Dunne MM; Ramtoola Z; Corrigan OI J Microencapsul; 2009 Aug; 26(5):403-10. PubMed ID: 18785053 [TBL] [Abstract][Full Text] [Related]
24. Preparation of sustained release microparticles with improved initial release property. Jung GY; Na YE; Park MS; Park CS; Myung PK Arch Pharm Res; 2009 Mar; 32(3):359-65. PubMed ID: 19387579 [TBL] [Abstract][Full Text] [Related]
25. Effect of the size of biodegradable microparticles on drug release: experiment and theory. Siepmann J; Faisant N; Akiki J; Richard J; Benoit JP J Control Release; 2004 Apr; 96(1):123-34. PubMed ID: 15063035 [TBL] [Abstract][Full Text] [Related]
26. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation. Jiang Y; Wang F; Xu H; Liu H; Meng Q; Liu W Int J Pharm; 2014 Nov; 475(1-2):475-84. PubMed ID: 25219858 [TBL] [Abstract][Full Text] [Related]
27. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles. Keohane K; Brennan D; Galvin P; Griffin BT Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950 [TBL] [Abstract][Full Text] [Related]
28. Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencapsulation method. Elkharraz K; Ahmed AR; Dashevsky A; Bodmeier R Int J Pharm; 2011 May; 409(1-2):89-95. PubMed ID: 21356287 [TBL] [Abstract][Full Text] [Related]
29. Preparation, characterization and in vitro release study of BSA-loaded double-walled glucose-poly(lactide-co-glycolide) microspheres. Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Mohamed F; Doolaanea AA; Kamaruzzaman YB Arch Pharm Res; 2016 Sep; 39(9):1242-56. PubMed ID: 26818028 [TBL] [Abstract][Full Text] [Related]
31. Design and characterization of sustained release ketoprofen entrapped carnauba wax microparticles. Oliveira RB; Nascimento TL; Lima EM Drug Dev Ind Pharm; 2012 Jan; 38(1):1-11. PubMed ID: 21671838 [TBL] [Abstract][Full Text] [Related]
32. A Flow Imaging Microscopy-Based Method Using Mass-to-Volume Ratio to Derive the Porosity of PLGA Microparticles. Sediq AS; Waasdorp SKD; Nejadnik MR; van Beers MMC; Meulenaar J; Verrijk R; Jiskoot W J Pharm Sci; 2017 Nov; 106(11):3378-3384. PubMed ID: 28755925 [TBL] [Abstract][Full Text] [Related]
33. Preparation of preformed porous PLGA microparticles and antisense oligonucleotides loading. Ahmed AR; Bodmeier R Eur J Pharm Biopharm; 2009 Feb; 71(2):264-70. PubMed ID: 18840521 [TBL] [Abstract][Full Text] [Related]
34. Critical attributes of formulation and of elaboration process of PLGA-protein microparticles. Martín-Sabroso C; Fraguas-Sánchez AI; Aparicio-Blanco J; Cano-Abad MF; Torres-Suárez AI Int J Pharm; 2015 Mar; 480(1-2):27-36. PubMed ID: 25578370 [TBL] [Abstract][Full Text] [Related]
35. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer. Ahmed AR; Elkharraz K; Irfan M; Bodmeier R Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130 [TBL] [Abstract][Full Text] [Related]
36. Three-dimensional poly(lactic-co-glycolic acid)/silica colloidal crystal microparticles for sustained drug release and visualized monitoring. Guo R; Sun XT; Zhang Y; Wang DN; Yang CG; Xu ZR J Colloid Interface Sci; 2018 Nov; 530():465-472. PubMed ID: 29990782 [TBL] [Abstract][Full Text] [Related]
37. Formulation and characterization of microspheres loaded with imatinib for sustained delivery. Ramazani F; Chen W; Van Nostrum CF; Storm G; Kiessling F; Lammers T; Hennink WE; Kok RJ Int J Pharm; 2015 Mar; 482(1-2):123-30. PubMed ID: 25636301 [TBL] [Abstract][Full Text] [Related]
38. New high throughput screening method for drug release measurements. Pelczarska A; Delie F; Domańska U; Carrupt PA; Martel S Eur J Pharm Biopharm; 2013 Sep; 85(1):151-7. PubMed ID: 23958326 [TBL] [Abstract][Full Text] [Related]
39. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method. Kang J; Wu F; Cai Y; Xu M; He M; Yuan W Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681 [TBL] [Abstract][Full Text] [Related]
40. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification. Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]